- Home
- FENC vs ELME Comparison
FENC vs ELME Comparison
Compare FENC & ELME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FENC | ELME |
|---|---|---|
| Founded | 1996 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 230.8M | 191.9M |
| IPO Year | 2010 | 1994 |
Fundamental Metrics
Financial Performance| Metric | FENC | ELME |
|---|---|---|
| Price | $9.69 | $2.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $14.50 | $12.67 |
| AVG Volume (30 Days) | 257.1K | ★ 1.2M |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 707.44% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $44,642,000.00 | ★ $206,360,000.00 |
| Revenue This Year | $65.12 | $5.03 |
| Revenue Next Year | $41.08 | $4.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.65 | $1.98 |
| 52 Week High | $10.27 | $17.68 |
Technical Indicators
Market Signals| Indicator | FENC | ELME |
|---|---|---|
| Relative Strength Index (RSI) | 76.50 | 35.17 |
| Support Level | $7.45 | $1.99 |
| Resistance Level | $9.92 | $2.19 |
| Average True Range (ATR) | 0.61 | 0.04 |
| MACD | 0.35 | -0.01 |
| Stochastic Oscillator | 86.85 | 7.50 |
Price Performance
Historical ComparisonAbout FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About ELME Elme Communities
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. It derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Elme Communities' tenants are banking, consulting, law, and financial services firms. The company operates in a single reportable segment which includes the ownership, development, redevelopment and acquisition of apartment communities.